Virginia Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

In the context of emergency prescriptions for controlled substances, especially Schedule II (CII) medications, regulations are in place to ensure both patient safety and compliance with federal law. When a pharmacist receives an oral prescription for an emergency CII medication, there is a specific expectation for follow-up documentation.

If the pharmacist does not receive the hard copy of the prescription from the prescriber within the required timeframe (usually within 7 days), the pharmacist has an obligation to notify the Drug Enforcement Administration (DEA). This requirement underscores the importance of maintaining proper documentation for controlled substances to prevent misuse or diversion.

Failing to receive the hard copy indicates a potential breach of protocol that could compromise the integrity of the prescription process, thus necessitating the pharmacist's action to inform the DEA of the situation. This action is crucial as it helps uphold regulatory standards, ensuring accountability in the handling of controlled substances.

The other options do not align with federal regulations regarding emergency CII prescriptions and would not meet the compliance requirements expected of pharmacists.